Canada markets closed

Entourage Health Corp. (ETRGF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0122+0.0024 (+24.24%)
At close: 03:33PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

    Strategic Cost Management Signals Stronger Financial Health and Future StabilityGross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase.Company demonstrates financial gains with a 23% reduction in the cost of goods sold.SG&A declined 14% compared to the previous year.Color Cannabis secures a #6 spot in the national pre-roll market. TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage"

  • GlobeNewswire

    Entourage Health to Report Fiscal Year 2023 Financial Results

    Company Financials for Full-Year 2023 will be filed after market close on April 29, 2024TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended December 31, 2023, after market close on April 29, 2024.

  • GlobeNewswire

    Entourage Health Provides Corporate Update

    Chief Legal Officer and Corporate Secretary to step down effective December 18, 2023 TORONTO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, today announced that Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, will step down to pursue other career opportunities, effective December 18, 2023. Mr. Doré joined Entourage Health